The second major limitation of this work was its retrospective design, the limited number of cases and the relative long inclusion period due to the rarity of PCa patients explored by PSMA-11 PET/CT in the setting of nonmetastatic PCa patients under ADT presenting a rise in PSA. Here, FOLH1 is linked to posterior cortical atrophy.